United States Over The Counter (OTC) Drugs Market by Product Type, Distribution Channel, End User 2024-2032
                     United States Over The 
Counter (OTC) Drugs 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " U n i t e d  S t a t e s  O v e r  T h e  C o u n t e r  
( O T C )  D r u g s  M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  
2 0 2 4 - 2 0 3 2 , "  t h e  U n i t e d  S t a t e s  o v e r  t h e  c o u n t e r  ( O T C )  d r u g s  m a r k e t  s i z e  r e a c h e d  U S $  
2 5 .4  B i l l i o n  i n  2 0 2 3 .
T h e  i n c r e a s i n g  h e a l t h  a w a r e n e s s  a m o n g  c o n s u m e r s  i n  t h e  U n i t e d  S t a t e s  d u e  t o  a c c e s s i b l e  
Report h e a l t h  i n f o r m a t i o n  t h r o u g h  d i g i t a l  m e d i a ,  p u b l i c  h e a l t h  c a m p a i g n s ,  a n d  e d u c a t i o n a l  
i n i t i a t i v e s  i s  s u p p o r t i n g  t h e  m a r k e t  g r o w th .  C o n s u m e r s  a r e  b e c o m i n g  m o r e  i n f o r m e d  a b o u t  
Highlight and h e a l t h  i s s u e s ,  p r e v e n t a t i v e  m e a s u r e s ,  a n d  t h e  r o l e  o f  o v e r  t h e  c o u n t e r  ( O T C )  m e d i c a t i o n s  i n  m a i n t a i n i n g  h e a l t h  a n d  m a n a g i n g  m i n o r  a i l m e n t s .  
I t  e n c o u r a g e s  p r o a c t i v e  h e a l t h  m a n a g e m e n t  a m o n g  t h e  m a s s e s ,  l e a d i n g  t o  a  g r e a te r  
Description r e l i a n c e  o n  O T C  d r u g s  f o r  s e l f - t r e a t me n t .  F u r t h e r m o r e ,  t h e  s h i f t i n g  t r e n d  t o w a r d s  a  h e a l t h i e r  l i f e s t y l e ,  e m p h a s i z i n g  w e l l n e s s  a n d  d i s e a s e  p r e v e n t i o n ,  i s  a c t i n g  a s  a n o t h e r  
g r o w t h - i n d u c i n g  f a c to r .  M o r e o v e r ,  p e o p l e  a r e  i n c r e a s i n g l y  t u r n i n g  t o  O T C  m e d i c a t i o n s  a s  
a  f i r s t  l i n e  o f  d e fe n s e  a g a i n s t  c o m m o n  h e a l t h  p r o b l e m s ,  r e d u c i n g  t h e  n e e d  f o r  m e d i c a l  
c o n s u l t a t i o n s  f o r  m i n o r  c o n d i t i o n s ,  w h i c h  i s  f u r t h e r  b o l s t e r i n g  t h e  m a r k e t  g r o w t h .
R e q u e s t  f o r  a  P D F  s a m p le  o f  t h is  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m /u n i t e d - s t a t e s - o v e r - t h e - c o u n t e r - d r u g s - m a r k e t / r e q u e s t s a m p l e
Report Description
United States Over The Counter  (OTC)  Drugs Market  Trends:
The easy ava i lab i l i ty  o f  OTC drugs in  var ious re ta i l  out le ts  l i ke  pharmacies,  supermarkets ,  and on l ine 
s tores,  mak ing them h igh ly  access ib le  to  consumers,  is  bo ls ter ing the market  growth.  Addi t iona l ly ,  the 
sh i f t ing t rend towards se l f -medicat ion,  dr iven by increased consumer knowledge and conf idence in  
managing minor  heal th  issues independent ly ,  i s  cont r ibut ing to  the market  growth.  
Bes ides th is ,  the in t roduct ion of  regula tory  suppor t ,  which has expanded the range of  ava i lab le  OTC 
medicat ions,  prov id ing consumers wi th  more opt ions for  se l f -care,  is  dr iv ing the market  growth.  
Fur thermore,  the r is ing investment  in  research and development  (R&D) to  in t roduce new OTC products  and 
improve ex is t ing ones is  suppor t ing the market  growth.
View Report  TOC,  Figures and Tables :  
ht tps: / /www.imarcgroup.com/united-states-over- the-counter -drugs-market
Breakup by Product Type:
• Cough, Cold and Flu Products
• Analgesics
• Dermatology Products
• Gastrointest inal  Products
• Vitamins,  Minerals and Supplements (VMS)
Report • Weight- loss/Dietary Products
Segmentation • Ophthalmic Products
• Sleeping Aids
• Others
Breakup by Route of Administration:
• Oral
• Parenteral
• Topical
• Others
Breakup by Dosage Form:
Report • Tablets and Capsules
• Liquids
Segmentation
• Ointments
• Others
Breakup by Distribution Channel:
• Hospital  Pharmacies
• Retai l  Pharmacies
• Online Pharmacies
• Others
Breakup by Region:
• Northeast
Report • Midwest
• South
Segmentation
• West
What is the expected growth rate of the United States 
over the counter (OTC) drugs market during 2024-2032?
What are the key factors driving the United States over 
the counter (OTC) drugs market?
What has been the impact of COVID-19 on the United 
Key States over the counter (OTC) drugs market?
Questions What is the breakup of the United States over the 
counter (OTC) drugs market based on the product type?
Answered in 
What is the breakup of the United States over the 
counter (OTC) drugs market based on route of 
the Report administration?
What is the breakup of the United States over the 
counter (OTC) drugs market based on the dosage form?
What is the breakup of the United States over the 
counter (OTC) drugs market based on the distribution 
channel?
What are the key regions in the United States over the 
counter (OTC) drugs market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     U n i t e d  S t a t e s  O v e r  T h e  C o u n t e r  ( O T C )  D r u g s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     C o u g h ,  C o l d  a n d  F l u  P r o d u c t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     A n a l g e s i c s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     D e r m a t o l o g y  P r o d u c t s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     G a s t r o i n t e s t i n a l  P r o d u c t s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     V i t a m i n s ,  M i n e r a l s  a n d  S u p p l e m e n t s  ( V M S )
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     W e i g h t - l o s s / D i e t a r y  P r o d u c t s
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t
    6 . 7     O p h t h a l m i c  P r o d u c t s
Table of         6 . 7 . 1  M a r k e t  T r e n d s        6 . 7 . 2  M a r k e t  F o r e c a s t
    6 . 8     S l e e p i n g  A i d s
        6 . 8 . 1  M a r k e t  T r e n d s
Contents         6 . 8 . 2  M a r k e t  F o r e c a s t
    6 . 9     O t h e r s
        6 . 9 . 1  M a r k e t  T r e n d s
        6 . 9 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  R o u t e  o f  A d m i n i s t r a t i o n
    7 . 1     O r a l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     P a r e n t e r a l
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     T o p i c a l
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /u n i t ed - s ta t es - o v e r- t he - c o unte r-
d ru gs -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]